Sun Pharma, Lupin, Dr. Reddy's Recall Products in US over Manufacturing Defects and Product Mix-Ups
Three of India’s top pharmaceutical companies—Sun Pharma, Lupin, and Dr. Reddy’s Laboratories—have initiated product recalls in the United States following manufacturing issues and product mix-ups, as per information released by the US Food and Drug Administration (USFDA).
Manufacturing | 28/07/2025 | By Darshana | 179
Simtra BioPharma Solutions, a global CDMO specializing in injectable medicines, has acquired a 65-acre property near its Bloomington, Indiana facility to expand US manufacturing capacity, particularly for oncology-focused injectable drug products.
Manufacturing | 26/07/2025 | By Mrinmoy Dey | 102
Delhi HC Rejects Roche Plea to Disclose Zydus' Manufacturing Process for Breast Cancer Drug Sigrima
The Delhi High Court has declined to direct Zydus Lifesciences to disclose the manufacturing process of its breast cancer drug Sigrima, stating that F. Hoffmann-La Roche failed to meet the mandatory requirements under Section 104A of the Patents Act, 1970.
Manufacturing | 26/07/2025 | By Darshana | 111
Colorcon Opens New Film Coating Manufacturing Facility in Malaysia
Colorcon has inaugurated a new, state-of-the-art 200,000 sq. ft. film coating manufacturing facility in Johor, Malaysia, to strengthen its supply capabilities and support pharmaceutical customers across the Asia Pacific region.
Manufacturing | 25/07/2025 | By Mrinmoy Dey | 108
Ampersand Capital Partners Acquires CurTec to Strengthen Specialty Packaging Manufacturing Portfolio
Its products are engineered to protect sensitive, high-value materials from contamination, moisture, and damage during transport and storage, while also complying with rigorous international regulatory standards.
Manufacturing | 23/07/2025 | By Darshana | 141
Klotho Neurosciences Parteners with AAVnerGene to Manufacture Gene Therapy Assets
Klotho Neurosciences has partnered with AAVnerGene to leverage its next-generation AAV manufacturing and targeted delivery platforms, aiming to accelerate the clinical development of gene therapies for neurological and age-related diseases.
Manufacturing | 23/07/2025 | By Mrinmoy Dey
As of late 2024, WuXi Biologics has successfully passed 42 regulatory inspections, including 22 by the EU EMA and the FDA. Additionally, the company has received 97 license approvals from regulatory agencies around the world.
Manufacturing | 23/07/2025 | By Darshana
Cipla Backs iCaltech to Accelerate Innovation in Medical Device Manufacturing
iCaltech, an ISO13485-certified firm, specialises in the development and commercialisation of regulatory-approved diagnostic equipment, particularly for respiratory care. The company designs, manufactures, and markets innovative medical technologies.
Manufacturing | 22/07/2025 | By Darshana | 113
This acquisition builds on a successful partnership between the two companies, helping meet a critical market gap in early-phase clinical trial supply. The facility in Boonton, New Jersey—now part of Aptar’s operations—is FDA-inspected and houses cGMP cleanrooms, suites for high-potency APIs and biologics, and advanced fill-finish technologies.
Manufacturing | 16/07/2025 | By Darshana | 140
Burkert and Siemens Strengthen Valve Island Integration for Process Manufacturing
The agreement ensures full compatibility between Bürkert’s advanced valve island technology and Siemens’ SIMATIC ecosystem, streamlining automation in highly regulated environments such as pharmaceutical, biotech, and food & beverage manufacturing.
Manufacturing | 14/07/2025 | By Darshana | 146
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy